As a part of agreement, Incyte has granted to Sun a limited, non-exclusive license to U.S. Patent and certainother related patents with respect to oral deuruxolitinib for certain agreed-upon non-hematology-oncology indications including alopecia areata, in the U.S.
Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S Read Post ยป
This July, the market is buzzing with fresh 5 SME and 2 Main listings. From promising startups to established giants going public
๐ก๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐ญ๐จ ๐ฉ๐จ๐ฌ๐ญ #๐๐๐ ๐๐๐ ๐๐๐ฌ๐ฎ๐ฅ๐ญ๐ฌ ๐ญ๐จ๐๐๐ฒ GM Breweries๐นHDB Financial Services๐นHDFC Life Insurance๐นHimadri Special Chemicals๐นICICI Lombard Genl. Insurance๐นICICI Prudential Insurance๐นJust
The companyโs IPO raised โน12,500 crore and started trading at โน835 per share, giving early investors a quick 13% bump over the issue price
